Aloe vera in the treatment for oral submucous fibrosis - a preliminary study
J Oral Pathol Med (2012) 41: 755–761 Background and objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available...
Saved in:
Published in: | Journal of oral pathology & medicine Vol. 41; no. 10; pp. 755 - 761 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford, UK
Blackwell Publishing Ltd
01-11-2012
Wiley |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | J Oral Pathol Med (2012) 41: 755–761
Background and objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF.
Methods: Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired ‘t’ test and unpaired ‘t’ test.
Results: Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild‐stage clinically and early‐stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group.
Interpretation and conclusion: Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients’ compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF. |
---|---|
AbstractList | J Oral Pathol Med
(2012)
41
: 755–761
Background and objectives:
Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF.
Methods:
Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired ‘
t
’ test and unpaired ‘
t
’ test.
Results:
Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild‐stage clinically and early‐stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (
P
= 0.008), improvement in mouth opening (
P
= 0.02), and cheek flexibility (
P
= 0.01) on comparing with the antioxidant group.
Interpretation and conclusion:
Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients’ compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF. Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF. Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired 't' test and unpaired 't' test. Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild-stage clinically and early-stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group. Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients' compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF. BACKGROUND AND OBJECTIVESOral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF.METHODSTwenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired 't' test and unpaired 't' test.RESULTSAloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild-stage clinically and early-stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group.INTERPRETATION AND CONCLUSIONOverall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients' compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF. J Oral Pathol Med (2012) 41: 755–761 Background and objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The pathogenesis is obscure, and till date, no definitive therapy is available for the management of OSMF. Hence, this preliminary study was carried out to compare the efficacy of Aloe vera with antioxidants in the treatment for OSMF. Methods: Twenty study subjects with OSMF were included in the study. Patients were divided into two groups. There were 10 patients in each group; group A subjects received 5 mg of aloe vera gel to be applied topically three times daily for 3 months and group B subjects received antioxidant capsules twice daily for 3 months. The results were analyzed with paired ‘t’ test and unpaired ‘t’ test. Results: Aloe vera responded better in all the parameters assessed and responded in all the clinicohistopathological stages particularly in those with mild‐stage clinically and early‐stage histopathologically. Aloe vera showed a statistically significant reduction in burning sensation (P = 0.008), improvement in mouth opening (P = 0.02), and cheek flexibility (P = 0.01) on comparing with the antioxidant group. Interpretation and conclusion: Overall assessment of the parameters depicted that Aloe vera group showed a better treatment response compared to the antioxidants group. It reduces the burning sensation and improves mouth opening thereby enhanced the patients’ compliance. It proves to be a relatively safe, can be applied topically, easily available, economical, noninvasive, and efficacious in the treatment for OSMF. |
Author | Sudarshan, Ramachandran Annigeri, Rajeshwari G. Sree Vijayabala, G. |
Author_xml | – sequence: 1 givenname: Ramachandran surname: Sudarshan fullname: Sudarshan, Ramachandran organization: Department of Oral Medicine and Radiology, Sibar Institute of Dental Sciences, Guntur, Andhra Pradesh, India – sequence: 2 givenname: Rajeshwari G. surname: Annigeri fullname: Annigeri, Rajeshwari G. organization: Department of Oral Medicine and Radiology, College of Dental Sciences & Hospital, Davangere, Karnataka, India – sequence: 3 givenname: G. surname: Sree Vijayabala fullname: Sree Vijayabala, G. organization: Department of Oral Medicine and Radiology, Thai Moogambikai Dental College and Hospital, Chennai, India |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26581304$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22650317$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkMtu1DAYhS1URKctr4C8QWKT1JfYThYsSqcXqlHbBYil5Ti_hYdcBjuBmbevwwzDFm9syd_xf_ydoZN-6AEhTElO07pc51QSkhFFi5wRynJCqSzz7Su0OF6coAWpSJExQdkpOotxTQhVvKBv0CljUhBO1QKtrtoB8C8IBvsej98BjwHM2EE_YjcEPATT4jjV3WSHKWLn6zBEH3GGDd4EaH3nexN2OI5Ts7tAr51pI7w97Ofo6-3Nl-v7bPV09_n6apXZgqsys5VghJWSNU1lBS-NAMfAFg2U1tU1LYFzxoSkdaOc5cw0RQlgnVOyASY4P0cf9u9uwvBzgjjqzkcLbWt6SC01pbySrBAVS2i5R23qHQM4vQm-S401JXp2qdd6VqZnZXp2qf-41NsUfXeYkr4PzTH4V14C3h8AE61pXTC99fEfJ0VJOSkS93HP_fYt7P67gH54ep5PKZ_t8z6OsD3mTfihpeJK6G-Pd3r5TG8_LdVSP_AX5QqgBg |
CitedBy_id | crossref_primary_10_1186_s12903_023_03488_9 crossref_primary_10_1111_odi_13544 crossref_primary_10_14450_2318_9312_v29_e4_a2017_pp284_301 crossref_primary_10_1007_s12032_022_01673_4 crossref_primary_10_1016_j_hermed_2015_04_005 crossref_primary_10_14260_jemds_2015_1959 crossref_primary_10_1016_j_oooo_2016_02_020 crossref_primary_10_3390_ma14123374 crossref_primary_10_3390_jpm12081272 crossref_primary_10_12998_wjcc_v2_i12_866 crossref_primary_10_5812_ijhrba_11358 crossref_primary_10_1002_hed_24249 crossref_primary_10_1111_jop_12463 crossref_primary_10_4103_ijc_IJC_128_21 crossref_primary_10_1590_1807_2577_02018 crossref_primary_10_1016_j_jormas_2023_101423 crossref_primary_10_1016_j_oooo_2016_07_023 crossref_primary_10_1111_jop_12789 crossref_primary_10_20473_j_djmkg_v53_i3_p115_121 crossref_primary_10_36106_ijsr_7128875 crossref_primary_10_1111_odi_14901 crossref_primary_10_1002_14651858_CD007156_pub3 crossref_primary_10_5005_jp_journals_10024_1406 crossref_primary_10_1016_S0011_8524_14_70161_8 crossref_primary_10_5005_jp_journals_10024_1806 crossref_primary_10_3390_antiox11050868 crossref_primary_10_1016_j_jobcr_2014_12_005 crossref_primary_10_1016_j_biopha_2016_09_096 crossref_primary_10_36106_ijsr_2410759 crossref_primary_10_14260_jemds_2021_246 crossref_primary_10_1111_prd_12277 crossref_primary_10_1016_j_jobcr_2020_08_004 crossref_primary_10_1111_jicd_12208 crossref_primary_10_5005_jp_journals_10057_0224 crossref_primary_10_1002_ptr_7202 crossref_primary_10_7759_cureus_47259 crossref_primary_10_1586_14737140_2013_842898 crossref_primary_10_1586_14737140_2014_842898 crossref_primary_10_1111_jop_13503 crossref_primary_10_3390_plants10102148 |
Cites_doi | 10.1007/BF02992043 10.4103/0970-9290.29865 10.1007/BF02872409 10.1002/1097-0142(19861215)58:12<2628::AID-CNCR2820581214>3.0.CO;2-Z 10.1111/j.1600-0714.1998.tb01915.x 10.1080/15376510309825 10.1016/0278-2391(88)90043-2 10.4103/0970-4388.26022 10.1016/j.tripleo.2006.07.011 10.1111/j.1601-0825.2011.01791.x 10.1111/j.1601-0825.2006.01313.x 10.1111/j.1600-0714.2007.00582.x 10.1038/bjc.1986.20 10.1016/S0901-5027(87)80064-4 10.1016/0030-4220(66)90367-7 10.1111/j.1600-0714.1990.tb00804.x 10.1016/0278-2391(91)90002-4 10.1034/j.1600-0714.2001.300103.x 10.3109/00016481003782041 10.5005/jp-journals-10011-1021 10.1034/j.1600-0714.2001.301007.x 10.1034/j.1600-0714.2000.290601.x 10.1111/j.1600-0714.2008.00696.x 10.1111/j.1600-0528.1985.tb00468.x 10.1016/S0901-5027(87)80055-3 10.1016/S0901-5027(05)80473-4 10.1111/j.1399-0039.1985.tb00946.x 10.1016/S0304-3835(97)00205-X 10.1007/BF02992406 10.1093/ajcp/81.5.623 |
ContentType | Journal Article |
Copyright | 2012 John Wiley & Sons A/S 2015 INIST-CNRS 2012 John Wiley & Sons A/S. |
Copyright_xml | – notice: 2012 John Wiley & Sons A/S – notice: 2015 INIST-CNRS – notice: 2012 John Wiley & Sons A/S. |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1111/j.1600-0714.2012.01168.x |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Dentistry |
EISSN | 1600-0714 |
EndPage | 761 |
ExternalDocumentID | 10_1111_j_1600_0714_2012_01168_x 22650317 26581304 JOP1168 ark_67375_WNG_DP1FBD7D_J |
Genre | article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 29L 31~ 33P 34H 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CWXXS D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 UDS V8K W8V W99 WBKPD WBNRW WIH WIJ WIK WOHZO WPGGZ WQJ WRC WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAJUZ AAUGY AAVGM ABCVL ABHUG ABPTK ACXME ADAWD ADDAD AFVGU AGJLS AKALU IQODW CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4378-c95202862dd9c538a5ef2ec4de8cfbb18e3322561bd7fc32ad48eecff76de2533 |
IEDL.DBID | 33P |
ISSN | 0904-2512 |
IngestDate | Sat Aug 17 00:49:08 EDT 2024 Fri Nov 22 00:39:08 EST 2024 Sat Sep 28 07:50:36 EDT 2024 Sun Oct 22 16:07:35 EDT 2023 Sat Aug 24 01:04:23 EDT 2024 Wed Oct 30 09:55:13 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | oral submucous fibrosis Treatment Stomatology antioxidants Fibrosis Oral administration aloe vera ENT Antioxidant |
Language | English |
License | CC BY 4.0 2012 John Wiley & Sons A/S. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4378-c95202862dd9c538a5ef2ec4de8cfbb18e3322561bd7fc32ad48eecff76de2533 |
Notes | istex:53A03AFB1A1FA3CB0F37710E2BF21A2141093084 ark:/67375/WNG-DP1FBD7D-J ArticleID:JOP1168 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
PMID | 22650317 |
PQID | 1139624592 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1139624592 crossref_primary_10_1111_j_1600_0714_2012_01168_x pubmed_primary_22650317 pascalfrancis_primary_26581304 wiley_primary_10_1111_j_1600_0714_2012_01168_x_JOP1168 istex_primary_ark_67375_WNG_DP1FBD7D_J |
PublicationCentury | 2000 |
PublicationDate | November 2012 |
PublicationDateYYYYMMDD | 2012-11-01 |
PublicationDate_xml | – month: 11 year: 2012 text: November 2012 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Frederiksberg – name: Denmark |
PublicationTitle | Journal of oral pathology & medicine |
PublicationTitleAlternate | J Oral Pathol Med |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Ltd Wiley |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley |
References | Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966; 22: 764-9. Gupta S, Reddi MVR, Harinath BC. Role of oxidative stress and antioxidants in etiopathogenesis and management of oral submucous fibrosis. Indian J Clin Biochem 2004; 19: 138-41. Rajendran R, Sugathan CK, Remani P, Ankathil R, Vijayakumar T. Cell mediated and humoral immune responses in oral submucous fibrosis. Cancer 1986; 58: 2628. Kerr AR, Warnakulasuriya S, Mighell AJ, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis 2011; 17: 42-57. Rajendran R, Raju GK, Nair SM, Balasubramanian G. Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, South India. Bull WHO 1992; 70: 783-9. Mathur RM, Jha T. Normal oral flexibility a guideline for OSMF cases. J Indian Dent Assoc 1993; 64: 139-43. Sharma JK, Gupta AK, Mukhija RD, Nigam P. Clinical experience with the use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 1987; 16: 695-9. Kumar A, Bagewadi A, Keluskar V, Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 207-13. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 1985; 13: 340-1. Haque MF, Meghji S, Nazir R, Harris M. Interferon gamma (IFN-γ) may reverse oral submucous fibrosis. J Oral Pathol Med 2001; 30: 12-21. Ahmad MS, Ali SA, Ali AS, Chaubey KK. Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India. J Indian Soc Pedod Prev Dent 2006; 24: 84-9. Cox S, Zoellner H. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. J Oral Pathol Med 2009; 38: 220-6. Borle RM, Borle SR. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991; 49: 788-91. Gupta D, Sharma SC. Oral submucous fibrosis - a new treatment regimen. J Oral Maxillofac Surg 1988; 46: 830-3. Sinor PN, Gupta PC, Murti PR, et al. A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 1990; 19: 94-8. Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chiang CP. Oral administration from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 2001; 30: 618-25. Prabhu SR, et al. Oral disease in the tropics. Delhi: Oxford University Press, 1993; 417-22. Gupta DS, Gupta MK, Golhar BL. Oral submucous fibrosis - a clinical study and management by physiofibrolysis (MWD). J Indian Dent Assoc 1980; 52: 375-8. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36: 575-80. Gupta SC, Yadav YC. "MISI" an etiologic factor in oral submucous fibrosis. Indian J Otolaryngol 1978; 30: 5-6. Phatak AG. Hypercoagulation and fibrinolysis in oral submucous fibrosis. Am J Clin Pathol 1984; 81: 623-8. Khanna JN, Andrade NN. Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 1995; 24: 433-9. Rao B. Oral submucous fibrosis - the Davangere Study. JIAOMR 1993; 4: 11-22. Davis RN. Biological activity of Aloe Vera. Seifen Oele Fette Wachse 1993; 119: 646-9. Pal P, Harman D, Sharma P, Verma N. Review: Antioxidant in oral health - Recent Scenario. JIAOMA 2004; 16: 119-28. Jalouli J, Ibrahim SO, Mehrotra R, et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 2010; 130: 1306-11. Hastak K, Lubri N, Jakhi SD, et al. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett 1997; 116: 265-9. Lin HJ, Lin JC. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Oral Dis 2007; 13: 407-13. Shah N, Sharma PP. Role of chewing and smoking habits in the etiology of OSMF: a case control study. J Oral Pathol Med 1998; 27: 475-9. Auluck A, Rosin MP, Zhang L, Sumanth KN. Oral Submucous Fibrosis, a Clinically Benign but Potentially Malignant Disease: report of 3 Cases and Review of the Literature. J Can Dent Assoc 2008; 74: 735-40. Phatak AG. Fibrin producing factor in oral submucous fibrosis. Indian J Orolaryngol 1979; 31: 103-4. Das AD, Balan A, Sreelatha KT. Comparative Study of the Efficacy of Curcumin and Turmeric Oil as Chemopreventive Agents in Oral Submucous Fibrosis: a Clinical and Histopathological Evaluation. JIAOMR 2010; 22: 88-92. Sinha SN, Jain PK. Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis. Indian J Otolaryngol 1979; 31: 72-5. Canniff JP, Batchelor JR, Dodi IA, Harvey W. HLA-typing in oral submucous fibrosis. Tissue Antigens 1985; 26: 138-42. Ipe V, Rajendran R, Sugathan CK, Vijayakumar T. Prevalence of oralsubmucous fibrosis among the cashew workers of Kerala South India. Indian J Cancer 1986; 23: 101-4. Adhvaryu SG, Bhatt RG, Dayal PK, et al. SCE frequencies in lymphocytes of tobaccobetel nut chewers and patients with oral submucous fibrosis. Br J Cancer 1986; 53: 141-3. Subapriya R, Kumaraguruparan R, Nagini S, Thangavelu A. Oxidant-antioxidant status in oral precancer and oral cancer patients. Toxicol Mech Methods 2003; 13: 77-81. Dorle RM, Jagtap MW. Estimation of complement C3 in oral submucous fibrosis. Int J Oral Maxillofac Surg 1987; 16: 753-6. Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 2006; 17: 190-8. Trivedy CR, Warnakulasuriya KA, Peters TJ, Senkus R, Hazarey VK, Johnson NW. Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 2000; 29: 241-8. 1998; 27 2007; 103 1997; 116 2000; 29 1984; 81 1986; 53 1978; 30 1990; 19 2006; 17 1993; 64 1986; 58 2003; 13 1993 2008; 74 1979; 31 2011; 17 1985; 26 2007; 13 2007; 36 1993; 4 1987; 16 2010; 22 1992; 70 1991; 49 1993; 119 2006; 24 2004; 19 1980; 52 2004; 16 1986; 23 1995; 24 2010; 130 1988; 46 1966; 22 2009; 38 2001; 30 1985; 13 Pal P (e_1_2_6_37_2) 2004; 16 Rajendran R (e_1_2_6_21_2) 1992; 70 e_1_2_6_31_2 e_1_2_6_30_2 Prabhu SR (e_1_2_6_13_2) 1993 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_35_2 Davis RN (e_1_2_6_40_2) 1993; 119 Phatak AG (e_1_2_6_10_2) 1979; 31 e_1_2_6_33_2 e_1_2_6_11_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_38_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_36_2 Ipe V (e_1_2_6_20_2) 1986; 23 e_1_2_6_41_2 Sinha SN (e_1_2_6_39_2) 1979; 31 Mathur RM (e_1_2_6_8_2) 1993; 64 Gupta SC (e_1_2_6_12_2) 1978; 30 e_1_2_6_7_2 Gupta DS (e_1_2_6_34_2) 1980; 52 Auluck A (e_1_2_6_4_2) 2008; 74 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_3_2 e_1_2_6_6_2 Rao B (e_1_2_6_32_2) 1993; 4 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2 |
References_xml | – volume: 22 start-page: 764 year: 1966 end-page: 9 article-title: Oral submucous fibrosis publication-title: Oral Surg Oral Med Oral Pathol – volume: 13 start-page: 340 year: 1985 end-page: 1 article-title: Malignant transformation rate in oral submucous fibrosis over a 17‐year period publication-title: Community Dent Oral Epidemiol – volume: 116 start-page: 265 year: 1997 end-page: 9 article-title: Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis publication-title: Cancer Lett – volume: 53 start-page: 141 year: 1986 end-page: 3 article-title: SCE frequencies in lymphocytes of tobaccobetel nut chewers and patients with oral submucous fibrosis publication-title: Br J Cancer – volume: 30 start-page: 618 year: 2001 end-page: 25 article-title: Oral administration from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis publication-title: J Oral Pathol Med – volume: 26 start-page: 138 year: 1985 end-page: 42 article-title: HLA‐typing in oral submucous fibrosis publication-title: Tissue Antigens – volume: 30 start-page: 5 year: 1978 end-page: 6 article-title: “MISI” an etiologic factor in oral submucous fibrosis publication-title: Indian J Otolaryngol – volume: 64 start-page: 139 year: 1993 end-page: 43 article-title: Normal oral flexibility a guideline for OSMF cases publication-title: J Indian Dent Assoc – volume: 49 start-page: 788 year: 1991 end-page: 91 article-title: Management of oral submucous fibrosis: a conservative approach publication-title: J Oral Maxillofac Surg – volume: 27 start-page: 475 year: 1998 end-page: 9 article-title: Role of chewing and smoking habits in the etiology of OSMF: a case control study publication-title: J Oral Pathol Med – volume: 36 start-page: 575 year: 2007 end-page: 80 article-title: Nomenclature and classification of potentially malignant disorders of the oral mucosa publication-title: J Oral Pathol Med – volume: 19 start-page: 138 year: 2004 end-page: 41 article-title: Role of oxidative stress and antioxidants in etiopathogenesis and management of oral submucous fibrosis publication-title: Indian J Clin Biochem – volume: 119 start-page: 646 year: 1993 end-page: 9 article-title: Biological activity of Aloe Vera publication-title: Seifen Oele Fette Wachse – start-page: 417 year: 1993 end-page: 22 – volume: 130 start-page: 1306 year: 2010 end-page: 11 article-title: Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India publication-title: Acta Otolaryngol – volume: 70 start-page: 783 year: 1992 end-page: 9 article-title: Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, South India publication-title: Bull WHO – volume: 23 start-page: 101 year: 1986 end-page: 4 article-title: Prevalence of oralsubmucous fibrosis among the cashew workers of Kerala South India publication-title: Indian J Cancer – volume: 52 start-page: 375 year: 1980 end-page: 8 article-title: Oral submucous fibrosis – a clinical study and management by physiofibrolysis (MWD) publication-title: J Indian Dent Assoc – volume: 24 start-page: 433 year: 1995 end-page: 9 article-title: Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases publication-title: Int J Oral Maxillofac Surg – volume: 13 start-page: 77 year: 2003 end-page: 81 article-title: Oxidant‐antioxidant status in oral precancer and oral cancer patients publication-title: Toxicol Mech Methods – volume: 16 start-page: 753 year: 1987 end-page: 6 article-title: Estimation of complement C3 in oral submucous fibrosis publication-title: Int J Oral Maxillofac Surg – volume: 29 start-page: 241 year: 2000 end-page: 8 article-title: Raised tissue copper levels in oral submucous fibrosis publication-title: J Oral Pathol Med – volume: 16 start-page: 695 year: 1987 end-page: 9 article-title: Clinical experience with the use of peripheral vasodilator in oral disorders publication-title: Int J Oral Maxillofac Surg – volume: 19 start-page: 94 year: 1990 end-page: 8 article-title: A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut publication-title: J Oral Pathol Med – volume: 58 start-page: 2628 year: 1986 article-title: Cell mediated and humoral immune responses in oral submucous fibrosis publication-title: Cancer – volume: 31 start-page: 103 year: 1979 end-page: 4 article-title: Fibrin producing factor in oral submucous fibrosis publication-title: Indian J Orolaryngol – volume: 16 start-page: 119 year: 2004 end-page: 28 article-title: Review: Antioxidant in oral health – Recent Scenario publication-title: JIAOMA – volume: 103 start-page: 207 year: 2007 end-page: 13 article-title: Efficacy of lycopene in the management of oral submucous fibrosis publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod – volume: 81 start-page: 623 year: 1984 end-page: 8 article-title: Hypercoagulation and fibrinolysis in oral submucous fibrosis publication-title: Am J Clin Pathol – volume: 31 start-page: 72 year: 1979 end-page: 5 article-title: Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis publication-title: Indian J Otolaryngol – volume: 22 start-page: 88 year: 2010 end-page: 92 article-title: Comparative Study of the Efficacy of Curcumin and Turmeric Oil as Chemopreventive Agents in Oral Submucous Fibrosis: a Clinical and Histopathological Evaluation publication-title: JIAOMR – volume: 30 start-page: 12 year: 2001 end-page: 21 article-title: Interferon gamma (IFN‐γ) may reverse oral submucous fibrosis publication-title: J Oral Pathol Med – volume: 13 start-page: 407 year: 2007 end-page: 13 article-title: Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function publication-title: Oral Dis – volume: 74 start-page: 735 year: 2008 end-page: 40 article-title: Oral Submucous Fibrosis, a Clinically Benign but Potentially Malignant Disease: report of 3 Cases and Review of the Literature publication-title: J Can Dent Assoc – volume: 17 start-page: 190 year: 2006 end-page: 8 article-title: Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis publication-title: Indian J Dent Res – volume: 24 start-page: 84 year: 2006 end-page: 9 article-title: Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India publication-title: J Indian Soc Pedod Prev Dent – volume: 4 start-page: 11 year: 1993 end-page: 22 article-title: Oral submucous fibrosis – the Davangere Study publication-title: JIAOMR – volume: 38 start-page: 220 year: 2009 end-page: 6 article-title: Physiotherapeutic treatment improves oral opening in oral submucous fibrosis publication-title: J Oral Pathol Med – volume: 46 start-page: 830 year: 1988 end-page: 3 article-title: Oral submucous fibrosis – a new treatment regimen publication-title: J Oral Maxillofac Surg – volume: 17 start-page: 42 year: 2011 end-page: 57 article-title: A systematic review of medical interventions for oral submucous fibrosis and future research opportunities publication-title: Oral Dis – volume: 16 start-page: 119 year: 2004 ident: e_1_2_6_37_2 article-title: Review: Antioxidant in oral health – Recent Scenario publication-title: JIAOMA contributor: fullname: Pal P – volume: 30 start-page: 5 year: 1978 ident: e_1_2_6_12_2 article-title: “MISI” an etiologic factor in oral submucous fibrosis publication-title: Indian J Otolaryngol doi: 10.1007/BF02992043 contributor: fullname: Gupta SC – ident: e_1_2_6_28_2 doi: 10.4103/0970-9290.29865 – ident: e_1_2_6_33_2 doi: 10.1007/BF02872409 – ident: e_1_2_6_18_2 doi: 10.1002/1097-0142(19861215)58:12<2628::AID-CNCR2820581214>3.0.CO;2-Z – ident: e_1_2_6_3_2 doi: 10.1111/j.1600-0714.1998.tb01915.x – ident: e_1_2_6_5_2 doi: 10.1080/15376510309825 – ident: e_1_2_6_23_2 doi: 10.1016/0278-2391(88)90043-2 – ident: e_1_2_6_11_2 doi: 10.4103/0970-4388.26022 – ident: e_1_2_6_31_2 doi: 10.1016/j.tripleo.2006.07.011 – ident: e_1_2_6_41_2 doi: 10.1111/j.1601-0825.2011.01791.x – volume: 64 start-page: 139 year: 1993 ident: e_1_2_6_8_2 article-title: Normal oral flexibility a guideline for OSMF cases publication-title: J Indian Dent Assoc contributor: fullname: Mathur RM – ident: e_1_2_6_26_2 doi: 10.1111/j.1601-0825.2006.01313.x – ident: e_1_2_6_2_2 doi: 10.1111/j.1600-0714.2007.00582.x – volume: 74 start-page: 735 year: 2008 ident: e_1_2_6_4_2 article-title: Oral Submucous Fibrosis, a Clinically Benign but Potentially Malignant Disease: report of 3 Cases and Review of the Literature publication-title: J Can Dent Assoc contributor: fullname: Auluck A – volume: 31 start-page: 72 year: 1979 ident: e_1_2_6_39_2 article-title: Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis publication-title: Indian J Otolaryngol contributor: fullname: Sinha SN – volume: 23 start-page: 101 year: 1986 ident: e_1_2_6_20_2 article-title: Prevalence of oralsubmucous fibrosis among the cashew workers of Kerala South India publication-title: Indian J Cancer contributor: fullname: Ipe V – ident: e_1_2_6_15_2 doi: 10.1038/bjc.1986.20 – volume: 119 start-page: 646 year: 1993 ident: e_1_2_6_40_2 article-title: Biological activity of Aloe Vera publication-title: Seifen Oele Fette Wachse contributor: fullname: Davis RN – ident: e_1_2_6_14_2 doi: 10.1016/S0901-5027(87)80064-4 – ident: e_1_2_6_9_2 doi: 10.1016/0030-4220(66)90367-7 – ident: e_1_2_6_36_2 doi: 10.1111/j.1600-0714.1990.tb00804.x – volume: 70 start-page: 783 year: 1992 ident: e_1_2_6_21_2 article-title: Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, South India publication-title: Bull WHO contributor: fullname: Rajendran R – ident: e_1_2_6_38_2 doi: 10.1016/0278-2391(91)90002-4 – ident: e_1_2_6_25_2 doi: 10.1034/j.1600-0714.2001.300103.x – volume: 52 start-page: 375 year: 1980 ident: e_1_2_6_34_2 article-title: Oral submucous fibrosis – a clinical study and management by physiofibrolysis (MWD) publication-title: J Indian Dent Assoc contributor: fullname: Gupta DS – ident: e_1_2_6_19_2 doi: 10.3109/00016481003782041 – ident: e_1_2_6_7_2 doi: 10.5005/jp-journals-10011-1021 – ident: e_1_2_6_29_2 doi: 10.1034/j.1600-0714.2001.301007.x – volume: 4 start-page: 11 year: 1993 ident: e_1_2_6_32_2 article-title: Oral submucous fibrosis – the Davangere Study publication-title: JIAOMR contributor: fullname: Rao B – ident: e_1_2_6_22_2 doi: 10.1034/j.1600-0714.2000.290601.x – ident: e_1_2_6_35_2 doi: 10.1111/j.1600-0714.2008.00696.x – ident: e_1_2_6_6_2 doi: 10.1111/j.1600-0528.1985.tb00468.x – start-page: 417 volume-title: Oral disease in the tropics year: 1993 ident: e_1_2_6_13_2 contributor: fullname: Prabhu SR – ident: e_1_2_6_27_2 doi: 10.1016/S0901-5027(87)80055-3 – ident: e_1_2_6_24_2 doi: 10.1016/S0901-5027(05)80473-4 – ident: e_1_2_6_16_2 doi: 10.1111/j.1399-0039.1985.tb00946.x – ident: e_1_2_6_30_2 doi: 10.1016/S0304-3835(97)00205-X – volume: 31 start-page: 103 year: 1979 ident: e_1_2_6_10_2 article-title: Fibrin producing factor in oral submucous fibrosis publication-title: Indian J Orolaryngol doi: 10.1007/BF02992406 contributor: fullname: Phatak AG – ident: e_1_2_6_17_2 doi: 10.1093/ajcp/81.5.623 |
SSID | ssj0017341 |
Score | 2.3204808 |
Snippet | J Oral Pathol Med (2012) 41: 755–761
Background and objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly... Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing gutka and betel quid. The... J Oral Pathol Med (2012) 41 : 755–761 Background and objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly... BACKGROUND AND OBJECTIVESOral submucous fibrosis (OSMF) is a potentially malignant disorder of the oral mucosa, mainly associated with the practice of chewing... |
SourceID | proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 755 |
SubjectTerms | Administration, Topical Adolescent Adult Aloe aloe vera antioxidants Antioxidants - therapeutic use Biological and medical sciences Dentistry Female Gels Humans Male Medical sciences oral submucous fibrosis Oral Submucous Fibrosis - drug therapy Otorhinolaryngology. Stomatology Phytotherapy - methods Plant Extracts - therapeutic use Severity of Illness Index Treatment Outcome Young Adult |
Title | Aloe vera in the treatment for oral submucous fibrosis - a preliminary study |
URI | https://api.istex.fr/ark:/67375/WNG-DP1FBD7D-J/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0714.2012.01168.x https://www.ncbi.nlm.nih.gov/pubmed/22650317 https://search.proquest.com/docview/1139624592 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BOcClvNtQqIyEuAXVjzjOsTRd0B6WlQDBzXJsR6qg2WrDSj3yH_iH_BJmnG4gUg8IcYsiTTSZ8cx8tucB8EJWLratFznGKpOrgBgOQazOg9SR2q052aQhtu_LxWdTn1KbnPm2FmboDzEeuJFlJH9NBu6afmrkmqqiS05HI3Skx7k2rwhP4qYhVXPI5XihUMo0xPKoOlI5hfRpUs-1H5pEqlsk9EvKnHQ9Cq8dpl5cB0unKDeFqdnd__mD92D3Cqyy42F13YcbsXsAt2tKMKIZcQ9hcfx1FRlag2NnHUMsycbEdYZomFH5P-uR4Y1fbXrWIj-r_qxnP7__YI5drJHD81QQzFKb20fwcXb64eRtfjWhIfdK4vbTV4VAgKJFCJVH1-mK2IroVYjGt03DTZTkMDRvQtl6KVxQJkbftqUOUSDSfAw73aqL-8AQpprAeTC6Cko10jQG14lwvtBOcBkz4Ftt2IuhEYf9YwODkrIkKUuSsklS9jKDl0ltI4Fbf6FEtrKwnxZvbL3ks9d1Wdt5BocTvY4EAgEaRnmVwfOtoi3aH12quC6i5JABWWmhikpksDesgN_USI5Os8xAJ0X_NeN2_m5JT0_-lfAA7tDroWjyKex8W2_iM7jZh81hsotftw0Inw |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BeygX3pTwKEZC3ILqxzrOsZAupS3LShTBzXJsR6qAbLVhpR75D_xDfgkzTjcQqQeEuOWQiSbz8Hy25wHwTJYuNo0XOcYqk6uAGA5BrM6D1JHarTlZpyG274vZJ1PtU5uco3UtTN8fYjhwI89I6zU5OB1Ij71cU1l0welshM70ONfmBQLKTaXRLqmeQ86HK4VCpjGWu-Wuyimoj9N6Lv3SKFZtktjPKXfSdSi-pp97cRkwHePcFKimN_7rL96E6xd4le31BnYLrsT2NmxVlGNEY-LuwGzvyyIydAjHTluGcJINuesMATGjDgCsQ45XfrHqWIMMLbrTjv38_oM5drZEFr-mmmCWOt3ehQ_T_ZNXB_nFkIbcK4k7UF9OBGIULUIoPa6ebhIbEb0K0fimrrmJktYMzetQNF4KF5SJ0TdNoUMUCDbvwUa7aON9YIhUTeA8GF0GpWppaoOmIpyfaCe4jBnwtTrsWd-Lw_6xh0FJWZKUJUnZJCl7nsHzpLeBwC0_Uy5bMbEfZ69tNefTl1VR2cMMdkaKHQgEYjQM9CqDp2tNW3RBuldxbUTJIQOy1EJNSpHBdm8Cv6mRHNfNIgOdNP3XjNvDd3N6evCvhE9g6-Dk7bE9fjM7egjX6JW-hvIRbHxbruJjuNqF1U5ykl9_mQzH |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaglaAX3oXwKEZC3ILqRxznWEgXWNCyEq3gZjl-SFVpdrVhpR75D_xDfgkzTjcQqQeEuOWQiSYznpnP9jwIeS4qG2J0PIdYpXPpAcMBiFW5FypguzUrmjTE9lM5-6LrQ2yTM93UwvT9IYYDN7SM5K_RwJc-jo1cYVV0yfBoBI_0GFP6JeDJbQmoHPvoCzEfbhRKkaZY7lf7MseYPs7qufRLo1C1jVI_x9RJ24H0Yj_24jJcOoa5KU5Nbv7PP7xFblygVXrQL6_b5Epo75DrNWYY4ZC4u2R28HURKJiDpSctBTBJh8x1CnCYYv0_7YDhtVusOxqBn0V30tGf339QS5cr4PAsVQTT1Of2HjmeHB69fptfjGjInRSw_3RVwQGhKO595cB32iJEHpz0QbvYNEwHgR5DscaX0QluvdQhuBhL5QMHqLlLttpFGx4QCjhVe8a8VpWXshG60bBQuHWFspyJkBG20YZZ9p04zB87GJCUQUkZlJRJkjLnGXmR1DYQ2NUpZrKVhfk8e2PqOZu8qsvaTDOyN9LrQMABoUGYlxl5tlG0AQPEWxXbBpAcMCAqxWVR8Yzc71fAb2ogB69ZZkQlRf8142b6cY5PD_-V8Cm5Nq8n5sO72ftHZAff6AsoH5Otb6t1eEKudn69l0zkFxxrC20 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aloe+vera+in+the+treatment+for+oral+submucous+fibrosis+%E2%80%93+a+preliminary+study&rft.jtitle=Journal+of+oral+pathology+%26+medicine&rft.au=Sudarshan%2C+Ramachandran&rft.au=Annigeri%2C+Rajeshwari+G.&rft.au=Sree+Vijayabala%2C+G.&rft.date=2012-11-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0904-2512&rft.eissn=1600-0714&rft.volume=41&rft.issue=10&rft.spage=755&rft.epage=761&rft_id=info:doi/10.1111%2Fj.1600-0714.2012.01168.x&rft.externalDBID=10.1111%252Fj.1600-0714.2012.01168.x&rft.externalDocID=JOP1168 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0904-2512&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0904-2512&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0904-2512&client=summon |